186 related articles for article (PubMed ID: 30693115)
21. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
Suppakitjanusant P; Ji Y; Stevenson MO; Chantrapanichkul P; Sineath RC; Goodman M; Alvarez JA; Tangpricha V
J Clin Transl Endocrinol; 2020 Sep; 21():100230. PubMed ID: 32685379
[TBL] [Abstract][Full Text] [Related]
22. The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand.
Ittiphisit S; Amponnavarat S; Manaboriboon N; Korpaisarn S
Sex Med; 2022 Jun; 10(3):100513. PubMed ID: 35428019
[TBL] [Abstract][Full Text] [Related]
23. Pregnancy in a Transgender Male: A Case Report and Review of the Literature.
Hassan A; Perini J; Khan A; Iyer A
Case Rep Endocrinol; 2022; 2022():6246867. PubMed ID: 35812019
[TBL] [Abstract][Full Text] [Related]
24. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
Zaliznyak M; Jung EE; Bresee C; Garcia MM
J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
[TBL] [Abstract][Full Text] [Related]
25. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
Porter K; Rosenzweig MQ
J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
[No Abstract] [Full Text] [Related]
26. Persistent vaginal bleeding during gender-affirming hormone therapy in transgender men.
da Silva ED; Spritzer PM; Fighera TM
J Endocrinol Invest; 2024 Feb; ():. PubMed ID: 38300501
[TBL] [Abstract][Full Text] [Related]
27. Pathologic Evaluation of Breast Tissue From Transmasculine Individuals Undergoing Gender-Affirming Chest Masculinization.
Hernandez A; Schwartz CJ; Warfield D; Thomas KM; Bluebond-Langner R; Ozerdem U; Darvishian F
Arch Pathol Lab Med; 2020 Jul; 144(7):888-893. PubMed ID: 31816268
[TBL] [Abstract][Full Text] [Related]
28. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
[TBL] [Abstract][Full Text] [Related]
29. Gender-Affirming Hormone Therapy and Bone Health: Do Different Regimens Influence Outcomes in Transgender Adults? A Narrative Review and Call for Future Studies.
Cirrincione LR; Narla RR
J Appl Lab Med; 2021 Jan; 6(1):219-235. PubMed ID: 33432334
[TBL] [Abstract][Full Text] [Related]
30. Gynecomastia in a Transgender Boy: A Case Report.
Fung R; Greenaway MK; McEvenue G
AACE Clin Case Rep; 2021; 7(6):350-352. PubMed ID: 34765730
[TBL] [Abstract][Full Text] [Related]
31. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
[TBL] [Abstract][Full Text] [Related]
32. Assessment of Gender-Affirming Hormone Therapy Requirements.
Fernandez JD; Kendjorsky K; Narla A; Villasante-Tezanos AG; Tannock LR
LGBT Health; 2019 Apr; 6(3):101-106. PubMed ID: 30810452
[TBL] [Abstract][Full Text] [Related]
33. Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review.
Patel KT; Adeel S; Rodrigues Miragaya J; Tangpricha V
Endocr Pract; 2022 Dec; 28(12):1244-1252. PubMed ID: 36007714
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer in a transgender woman undergoing gender-affirming exogenous hormone therapy.
Villalba MD; Letter HP; Robinson KA; Maimone S
Radiol Case Rep; 2023 Jul; 18(7):2511-2513. PubMed ID: 37214332
[TBL] [Abstract][Full Text] [Related]
35. Testosterone therapy and breast histopathological features in transgender individuals.
Baker GM; Guzman-Arocho YD; Bret-Mounet VC; Torous VF; Schnitt SJ; Tobias AM; Bartlett RA; Fein-Zachary VJ; Collins LC; Wulf GM; Heng YJ
Mod Pathol; 2021 Jan; 34(1):85-94. PubMed ID: 32939016
[TBL] [Abstract][Full Text] [Related]
36. Breakthrough Bleeding in Transgender and Gender Diverse Adolescents and Young Adults on Long-Term Testosterone.
Grimstad F; Kremen J; Shim J; Charlton BM; Boskey ER
J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):706-716. PubMed ID: 33910088
[TBL] [Abstract][Full Text] [Related]
37. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
[TBL] [Abstract][Full Text] [Related]
38. Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy.
Greene DN; Schmidt RL; Winston McPherson G; Rongitsch J; Imborek KL; Dickerson JA; Drees JC; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2021 Jan; 6(1):15-26. PubMed ID: 32674116
[TBL] [Abstract][Full Text] [Related]
39. Invasive breast cancer after initiation of testosterone replacement therapy in a man--a warning to endocrinologists.
Thomas SR; Evans PJ; Holland PA; Biswas M
Endocr Pract; 2008 Mar; 14(2):201-3. PubMed ID: 18308658
[TBL] [Abstract][Full Text] [Related]
40. The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer center in India.
Das U; Lakshmaiah KC; Govind Babu K; Suresh TM; Lokanatha D; Jacob L; Babu S
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1777-82. PubMed ID: 24894013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
